Alvesco for the therapy of persistent asthma with or without allergic component
18 Years +
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Sept 2016 by AstraZeneca
No locations available
A prospective one-arm non-interventional study with asthma patients treated with Alvesco.
This is an observational study. Therefore, the physician decides about dosage according to individual needs.
Other Name: Ciclesonide